PharmaShots | Incisive News in 3 Shots

Subscribe Now

Capricor Therapeutics

Capricor Therapeutics Publishes Results of CAP-1002 in P-II (HOPE-2) Trial for Late-Stage Duchenne Muscular Dystrophy in The Lancet

Capricor Therapeutics Publishes Results of CAP-1002 in P-II (HOPE-2) Trial for Late-Stage Duchenne Muscular Dystrophy in The Lance...

March 14, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us